News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted to the United States Food and Drug Administration
PsyBio Therapeutics
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
Mind Medicine (MindMed)
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers
MINDCURE
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders
Tryp Therapeutics
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
NeonMind Biosciences Inc.
Psyched Wellness Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund (ETF)
Psyched Wellness
Algernon Pharmaceuticals Announces the Appointment of Dr. Mark Williams to the Board of Directors
Algernon Pharmaceuticals
Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data
Mydecine Innovations Group
DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder
ATAI Life Sciences
Ketamine One Signs LOI with Veteran Services USA to Open Therapy Center
Wellbeing Digital Sciences
Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1
Psyched Wellness
PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund
Pharmather
MindMed Announces Participation at Upcoming Investor Conferences
Mind Medicine (MindMed)
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.